Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion type Assertion NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_head.
- NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_provenance.
- NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion evidence source_evidence_literature NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_provenance.
- NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion SIO_000772 22170433 NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_provenance.
- NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion wasDerivedFrom befree-2016 NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_provenance.
- NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion wasGeneratedBy ECO_0000203 NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_provenance.